Antipsychotic-Exposed Youths Have Increased T2DM Risk

This article originally appeared here.
Share this content:
Antipsychotic-Exposed Youths Have Increased T2DM Risk
Antipsychotic-Exposed Youths Have Increased T2DM Risk

WEDNESDAY, Jan. 20, 2016 (HealthDay News) -- Youths treated with antipsychotics have increased cumulative risk and exposure-adjusted incidence of type 2 diabetes mellitus (T2DM), according to research published online Jan. 20 in JAMA Psychiatry.

Britta Galling, M.D., from the North Shore-Long Island Jewish Health System in Glen Oaks, N.Y., and colleagues conducted a systematic literature search to examine the risk of T2DM associated with antipsychotic treatment in young people. Data were included from 13 studies, with 185,105 youths (mean age, 14.1 years) exposed to antipsychotics and 310,438 patient-years.

The researchers found that the cumulative T2DM risk was 5.72 per 1,000 patients for antipsychotic-exposed youths, with an incidence rate of 3.09 cases per 1,000 patient-years. Antipsychotic-exposed youths had significantly greater cumulative T2DM risk (odds ratio, 2.58) and incidence rate ratio (3.02) compared with healthy controls; cumulative T2DM risk and incidence rate ratios were also increased for antipsychotic-exposed youths versus psychiatric controls (odds ratio, 2.09; incidence rate ratio, 1.79). Greater cumulative T2DM risk was associated with longer follow-up, olanzapine prescription, and male sex, in multivariable meta-regression analysis of 10 studies. Incidence of T2DM was increased in association with second-generation antipsychotic prescription and less autism spectrum disorder diagnosis.

"Antipsychotics should be used judiciously and for the shortest necessary duration, and their efficacy and safety should be monitored proactively," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »